$CLDX Recent News Stock leaders flex muscles 2:58 p.m.

New Post Public Reply Private Reply Replies (0) Message Board

Apr 30, 2014 at 9:46 AM

$CLDX Recent News

Stock leaders flex muscles 2:58 p.m. Feb. 27, 2014 - The Trading Deck
S&P 500 rattles the cage on latest all-time high 12:28 p.m. Feb. 24, 2014 - Michael Ashbaugh
This tiny mutual fund is no. 1 for 2013 8:33 a.m. Jan. 7, 2014 - Suzanne McGee
Reading Wall Street’s tea leaves 3:44 p.m. Dec. 6, 2013 - The Trading Deck
Monthly jobs report triggers technical whipsaw 12:23 p.m. Sept. 6, 2013 - Michael Ashbaugh
Charting a market divergence 11:21 a.m. Aug. 22, 2013 - Michael Ashbaugh
Six stocks on the move 2:42 p.m. Aug. 21, 2013 - The Trading Deck
Charting a slow-motion test of major resistance 11:10 a.m. July 3, 2013 - Michael Ashbaugh
S&P 500 hesitates at the breakdown point 11:14 a.m. June 26, 2013 - Michael Ashbaugh
3 longs and 3 shorts to watch 3:22 p.m. June 12, 2013 - The Trading Deck
3 longs and 3 shorts to watch 2:33 p.m. April 17, 2013 - The Trading Deck
Hedge Funds have bought these stocks recently 3:04 p.m. April 12, 2013 - Insider Monkey
Hedge funds are bullish on these 5 stocks 8:38 a.m. Jan. 3, 2013 - Insider Monkey
Thursday’s top gaining and declining stocks 3:24 p.m. May 24, 2012 - MarketWatch
Friday’s biggest gaining and declining stocks 5:40 p.m. Feb. 24, 2012 - Kate Gibson
Celldex prices shares at 12% discount 12:26 p.m. Feb. 24, 2012 - MarketWatch.com
Rindopepimut ups brain cancer survival: Celdex 3:29 p.m. Nov. 21, 2011 - MarketWatch.com
Wednesday’s biggest gaining and declining stocks 3:33 p.m. May 18, 2011 - Kate Gibson
Celldex, Shire in drug-sector spotlight 1:35 p.m. May 18, 2011 - Val Brickates Kennedy
Celldex Therapeutics offer prices at 19% discount 9:48 a.m. May 18, 2011 - MarketWatch.com

Hottest Healthcare Stocks Now – CLDX LCI IMGN ALNY 2:15 p.m. April 29, 2014 - InvestorPlace.com
Cramer's Mad Money - A Trader's Trash Is An Investor's Treasure (4/17/14) 6:08 a.m. April 18, 2014 - Seeking Alpha
Trade-Ideas: Celldex Therapeutics (CLDX) Is Today's "Perilous Reversal" Stock 9:52 a.m. April 17, 2014 - TheStreet.com
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 1:02 p.m. April 16, 2014 - benzinga.com
Hottest Healthcare Stocks Now – QCOR IMGN LCI PCRX 8:15 a.m. April 9, 2014 - InvestorPlace.com
Encouraging Pre-Clinical Data from Celldex - Analyst Blog 5:40 p.m. April 8, 2014 - Zacks.com
A Sharp Pullback In Celldex Could Be A Window Of Opportunity 3:41 p.m. April 8, 2014 - Seeking Alpha
8 Biotech Events To Anticipate This Year: Part Two 5:04 p.m. April 7, 2014 - Seeking Alpha
Jefferies Biotech Stocks to Buy With Breakthrough Drug Innovations 7:56 a.m. April 3, 2014 - 247WallSt.com
'Mad Money' Lightning Round: I Want You to Buy Costco 6:00 a.m. April 3, 2014 - TheStreet.com
Cramer's Lightning Round - This Is The Right Level For Costco (4/2/14) 5:50 a.m. April 3, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Hope Springs Eternal 8:24 p.m. April 2, 2014 - TheStreet.com
3 Biotech Stocks Trading The Wrong Direction In March 4:58 p.m. March 28, 2014 - Seeking Alpha
Biggest Movers in Healthcare Stocks Now – EXAS CLDX CLVS HSP 1:30 p.m. March 27, 2014 - InvestorPlace.com
These Stocks Are Getting Hit Hardest During March's Biotech 'Correction' 2:35 p.m. March 25, 2014 - TheStreet.com
Mid-Afternoon Market Update: Markets Recover Slightly As Healthcare Stocks Continue to Show Weakness 2:33 p.m. March 24, 2014 - benzinga.com
Mid-Day Market Update: NASDAQ Tumbles 1.65%; Nu Skin Shares Surge After AIC China Review Update 11:48 a.m. March 24, 2014 - benzinga.com
Mid-Morning Market Update: Markets Mostly Lower; ReneSola Swings To Q4 Profit 9:35 a.m. March 24, 2014 - benzinga.com
Northwest Bio's German Smokescreen Obscures DCVax Problems 2:44 p.m. March 11, 2014 - TheStreet.com
Celldex Therapeutics Is Shutting Down CDX-1135: What Does It Mean? 3:11 p.m. March 10, 2014 - Seeking Alpha

Critical Alerts For Comcast, Gilead Sciences, Ciena, Adobe Systems, and Celldex Therapeutics Released By InvestorsObserver 9:31 a.m. April 29, 2014 - PR Newswire - PRF
Celldex's Phase 1 Study of CDX-1401 Published in Science Translational Medicine 2:01 p.m. April 16, 2014 - GlobeNewswire
Strategic Collaborations, Preclinical Studies Results, Patient Enrollment, Earnings Release Schedule, and Clinical Trial Initiations - Analyst Notes on Pacira, Celldex, Aegerion, Furiex, and Prothena 8:00 a.m. April 14, 2014 - PR Newswire - PRF
Celldex Therapeutics Establishes Preclinical Proof of Concept for New Antibody Drug Conjugate CDX-014; Data presented at AACR 2014 4:01 p.m. April 7, 2014 - GlobeNewswire
Celldex Therapeutics to Present Antibody-Drug Conjugate CDX-014 Preclinical Proof of Concept Data at AACR 2014 8:04 a.m. April 3, 2014 - GlobeNewswire
Critical Alerts For Starbucks, Verizon Communications, Du Pont, Celldex Therapeutics, and Level 3 Communications Released By InvestorsObserver 9:31 a.m. March 26, 2014 - PR Newswire - PRF
Technical Pointers - Top Gainers: Celldex Therapeutics, Sonus Networks, YOU On Demand Holdings, and CombiMatrix 9:12 a.m. March 18, 2014 - PR Newswire - PRF
Celldex Reports Fiscal 2013 Business/Financial Results and Outlines 2014 Strategy 9:03 a.m. March 3, 2014 - GlobeNewswire
Celldex to Report Fourth Quarter and Fiscal 2013 Business/Financial Results and Host 2014 Strategy Conference Call 2:30 p.m. Feb. 25, 2014 - GlobeNewswire
Critical Alerts For AT&T, Mastercard, Disney, Du Pont, and Celldex Therapeutics Released By InvestorsObserver 10:31 a.m. Feb. 12, 2014 - PR Newswire - PRF
Celldex Announces Upcoming Presentation at the 2014 Leerink Global Healthcare Conference 12:00 p.m. Feb. 6, 2014 - GlobeNewswire
Mentor Capital Cancer Immunotherapy Index Up 97% in 2013 12:02 p.m. Jan. 21, 2014 - BusinessWire - BZX
Critical Alerts For Facebook, DirecTV, Du Pont, BIDU, and Celldex Released By InvestorsObserver 10:31 a.m. Jan. 9, 2014 - PR Newswire
Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 9:00 a.m. Jan. 9, 2014 - PR Newswire
Clinical Study Updates, Collaborations, and Stock Price Updates - Research Report on Medtronic, Regeneron, Celldex, Cubist, and MannKind 9:00 a.m. Dec. 31, 2013 - PR Newswire
Health Care Sector Technical Data: XOMA, Celldex Therapeutics, Illumina, and Immunomedics 9:12 a.m. Dec. 19, 2013 - PR Newswire
Share Price Movements and Clinical Studies - Research Report on Celldex Therapeutics, Envision, MannKind, Covance, and Auxilium 9:00 a.m. Dec. 19, 2013 - PR Newswire
Clinical Trial Results, Partnerships, and Reimbursement Rates - Research Report on Celldex, Centene, Enanta, Novartis, and BG Medicine 9:00 a.m. Dec. 13, 2013 - PR Newswire
New Clinical Trials, Pricing of Common Stock and Adjusted Conversion of Convertible Senior Notes - Research Report on Regeneron, Celldex, PDL BioPharma, Amedisys, and Exelixis 9:00 a.m. Dec. 11, 2013 - PR Newswire
Celldex's CDX-301 in Combination with Mozobil(R) Increases Hematopoietic Stem Cell Mobilization and Results in Improved Transplantation of Mobilized Cells in Preclinical Studies; Results Presented at ASH 2013 9:30 a.m. Dec. 10, 2013 - GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fed Holds Steady, But CD Rates Climb: Savers' Edge

The Fed Sits Tight, But CD Rates Surge Isn't it a kicker when the Fed holds rates steady, yet the CD market is buzzing like a crowded trading floor on a bull run? We've seen the Federal Reserve hold its ground without budging interest rates, keeping everyone guessing while inflation's still a shadow in the corner. But the star of the show here isn't the Fed's poker...

CaringKind Merger Expands Alzheimer's Care in NY

A New Chapter for Dementia Care: The CaringKind Merger Cornerstone local relationships plus a fresh westerly breeze of national presence—that's the gist of the recent union between CaringKind and Alzheimer's Disease Resource Center. This isn't just a big deal for families in Nassau and Suffolk counties, it's a seismic shift for dementia care reaching across state...

Cat Financial Shows Solid Q3 Growth Amid Challenges

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

CallRail's New Insight Tool: Navigating the Competitive Landscape

How CallRail's New Feature Changes the Game Ever sit in a boardroom meeting and wonder what your lead numbers really mean? CallRail just dropped a new feature that could change that. This AI-powered platform is now decking its 225,000 businesses with market insights to not just know their numbers but to understand how they stack up against their competition in the same...

Celebrate Dr. David Neff's Healthcare Legacy

An Icon in Medicine and Innovation Dr. David R. Neff's recognition as a Pinnacle Lifetime Member marks a storied journey through medicine and healthcare innovation. Decades of Dedication to Patient Care For over 45 years, Neff carved out a niche in medicine that few can parallel. His overarching focus on infectious disease, cancer, and more represents a holistic approach...

Busch Gardens' Holiday Extravaganza Lights Up 2026

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

AST SpaceMobile Suit Seeks Lead Plaintiff by November 13

The Legal Rigmarole The market's got its knickers in a twist over AST SpaceMobile, folks. If you've been dabbling in NASDAQ:ASTS between March '25 and mid-July '26, it's time to perk up those ears. The legal eagles at Robbins Geller Rudman & Dowd LLP are rallying the troops for a class action lawsuit with you front and center. Deadline's looming on November 13, 2026, for...

Bulletproof Gets Nod for AI Expertise, Eyes Future Growth

Bulletproof's Recognition: A Sign of AI Prowess Let's dive right into today's news: Bulletproof just snagged a spot on the 2026 CRN AI Innovators list. Now, this is big leagues stuff, especially since this list highlights the top dogs in the AI space across North America. We're talking about managed service providers, value-added resellers, and all those tech wizards who...

Unpacking NOMMA's Unique Blend of Education Strategies

Introducing NOMMA's Unique Approach Well, here’s one for the books—an educational model that smacks of good ol’ discipline and sharpens minds for what's beyond the classroom. Located in New Orleans, the Military and Maritime Academy, or NOMMA if you want to keep things snappy, serves up an education with a difference. Not only does it prepare cadets academically,...

Xyte's Record Quarter: Surging Demand & New CEO

Setting New Records in the AV Industry There's buzz in the air over in Hoboken, New Jersey. Xyte, the AI cloud maestro you're starting to hear about more and more, has just smashed its own records this past September. It's not just a flash in the pan, either—this isn't the first time they've knocked it out of the park. Thanks to burgeoning enterprise demand and a...